 |
市場調查報告書
商品編碼
1539327
糖生物學市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024-2033年Glycobiology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033 |
||||||
價格
簡介目錄
Persistence Market Research最近發布了一份關於全球糖生物學市場的詳細研究報告。該報告對市場推動因素、趨勢、機會和課題等關鍵市場動態進行了深入分析，提供了對市場結構的深入洞察。
主要洞察
- 糖生物學市場規模（2024 年）：17 億美元
- 預測市值（2033 年）：54 億美元
- 全球市場成長率（2024 年至 2033 年複合年增長率）：13.7%
糖生物學市場 - 報告範圍：
糖生物學市場包括對生物系統中糖鏈（聚醣）的結構、功能和生物學的研究和分析。糖生物學在理解各種生物過程（包括細胞訊號傳導、免疫反應和疾病進展）方面發揮著重要作用。市場按應用細分，例如藥物發現/開發、診斷、腫瘤學和免疫學。糖組學研究活動的增加、個人化醫療需求的成長以及聚醣分析技術的進步推動了成長。
推動市場成長的因素：
推動全球糖生物學市場有幾個關鍵因素。對生物製藥研發的日益關注以及糖生物學在藥物發現和疾病診斷中的日益應用是關鍵的成長動力。質譜和色譜技術的進步透過實現更準確、更有效率的聚醣分析來推動市場擴張。此外，癌症和糖尿病等慢性病的盛行率不斷上升，凸顯了糖生物學在開發標靶療法中的重要性，從而推動了市場成長。聚醣生物標記在早期疾病檢測中的廣泛使用以及對糖工程治療應用的興趣日益濃厚也對市場成長做出了重大貢獻。
市場阻礙因素：
儘管成長前景廣闊，但糖生物學市場面臨著聚醣分析的複雜性以及與先進糖生物學研究工具相關的高成本相關的課題。缺乏標準化方案以及對聚醣分析專業知識的需求可能會限制小型實驗室對糖生物學技術的採用，這可能會阻礙市場成長。此外，糖生物學與臨床實踐的整合仍處於起步階段，這為將研究成果轉化為治療應用帶來了課題。解決這些問題需要持續投資於培訓和教育，並開發具有成本效益的工具和技術，使更廣泛的研究人員和臨床醫生更容易了解糖生物學。
市場機會：
由於基於聚醣的診斷方法的日益普及以及對創新治療解決方案的需求不斷增長，該市場提供了巨大的機會。具有更高靈敏度和特異性的下一代聚醣分析工具的開發正在滿足對精準醫學日成長的需求。新興經濟體不斷擴大的研究活動以及學術機構和生物製藥公司之間不斷加強的合作提供了新的市場成長管道，並使得糖生物學在疾病治療和預防方面的新應用得以探索。戰略合作夥伴關係、對尖端技術的投資以及引入基於聚醣的個人化醫療對於利用新機會和保持市場領先地位至關重要。
本報告涵蓋的主要問題
- 推動全球糖生物學市場成長的關鍵因素是什麼？
- 糖生物學的哪些類型和應用正在引領各領域的採用？
- 技術進步如何影響糖生物學市場的競爭格局？
- 誰是糖生物學市場的主要參與者？ 他們採取哪些策略來保持競爭力？
- 全球糖生物學市場的新趨勢和未來前景是什麼？
目錄
第1章 摘要整理
第2章 市場概要
- 市場範圍/分類
- 市場定義/範圍/限制
- 包含和排除
第3章 主要市場趨勢
- 影響市場的主要趨勢
- 產品革新/開發趨勢
第4章 重要成功要素
- 產品的採用/使用情形分析
- 產品的USP/特徵
- 最近產品認證與發售
- 大環境分析
- 波特分析
- 法規情勢
- 價值鏈分析
第5章 市場背景
- 宏觀經濟要素
- 預測要素- 相關性及影響
- 動態
第6章 COVID-19危機- 影響評估
- COVID-19及影響分析
- 各產品
- 各酵素
- 各應用領域
- 各終端用戶
- 各地區
- 2024年的市場情勢
第7章 全球市場的需求(金額及規模)分析
- 市場(金額)分析，2019～2023年
- 市場(金額)預測，2024～2033年
- 前一年同期比較成長趨勢分析
- 絕對的商機
第8章 各產品:全球市場分析
- 簡介/主要調查結果
- 市場規模(金額)分析，2019～2023年
- 市場規模(金額)分析與預測，2024～2033年
- 設備
- 酵素
- 消耗品
- 套件和試劑
- 各產品市場魅力分析
第9章 酵素:全球市場分析
- 簡介/主要調查結果
- 市場規模(金額)分析，2019～2023年
- 市場規模(金額)分析與預測，2024～2033年
- 半乳糖??
- 岩藻糖??
- 幾丁質?
- 乙醯氨基半乳糖??
- 肝素?
- PNGase F
- 其他
- GlcNAc轉移?
- 乙醯葡萄糖胺轉移?
- 外毒素
- 其他
- 岩藻糖基轉移?
- GalNAc 轉移?
- 半乳糖基轉移?
- 葡萄醣醛酸基轉移?
- 葡萄糖基轉移?
- 戊糖基轉移?
- 碳水化合物激?
- 神經氨酸?
- 唾液酸轉移?
- 其他
- 半乳糖??
- 各酵素市場魅力分析
第10章 各應用領域:全球市場分析
- 簡介/主要調查結果
- 市場規模(金額)分析，2019～2023年
- 市場規模(金額)分析與預測，2024～2033年
- 醫藥品的發現與開發
- 診斷應用
- 腫瘤學
- 免疫學
- 其他
- 產業用途
- 治療用途
- 腫瘤學
- 免疫學
- 其他
- 其他
- 各應用領域的市場魅力分析
第11章 各終端用戶全球市場分析
- 簡介/主要調查結果
- 市場規模(金額)分析，2019～2023年
- 市場規模(金額)分析與預測，2024～2033年
- 生物醫藥品企業
- 實驗室
- 醫院
- 診斷中心
- 受託研究機構
- 生物科技產業
- 學術機構
- 其他
- 各終端用戶市場魅力分析
第12章 各地區:全球市場分析
- 簡介
- 市場規模(金額)分析，2019～2023年
- 市場規模(金額)分析與預測，2024～2033年
- 北美
- 南美
- 歐洲
- 南亞
- 東亞
- 大洋洲
- 中東及非洲(中東·非洲)
- 各地區市場的魅力分析
第13章 北美市場分析
第14章 南美市場分析
第15章 歐洲市場分析
第16章 南亞市場分析
第17章 東亞市場分析
第18章 大洋洲市場分析
第19章 中東·非洲市場分析
第20章 市場結構分析
- 各級企業市場分析
- 主要企業的市場佔有率分析
- 市場影響分析
第21章 競爭分析
- 競爭儀表板
- 品牌和推銷策略
- 主要開發分析
- 競爭詳細內容
- Glycodiag
- Tracxn Technologies Limited
- Agilent Tecnologies, Inc.
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life,Inc.
- Z Biotech,LLC.
- Chemily Glycoscience
- Lectenz Bio
- 2BScientific
第22章 所使用的前提條件與縮寫
第23章 調查手法
簡介目錄
Product Code: PMRREP4769
Persistence Market Research has recently published an in-depth report on the global Glycobiology Market. This report provides a detailed analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, offering deep insights into the market structure.
Key Insights:
- Glycobiology Market Size (2024E): USD 1.7 Bn
- Projected Market Value (2033F): USD 5.4 Bn
- Global Market Growth Rate (CAGR 2024 to 2033): 13.7%
Glycobiology Market - Report Scope:
The Glycobiology Market involves the study and analysis of the structure, function, and biology of carbohydrates (glycans) in biological systems. Glycobiology plays a crucial role in understanding various biological processes, including cell signaling, immune response, and disease progression. The market is segmented by application, including drug discovery and development, diagnostics, oncology, and immunology, among others. Growth is driven by increasing research activities in glycomics, the rising demand for personalized medicine, and advancements in glycan analysis technologies.
Market Growth Drivers:
Several key factors are driving the global Glycobiology Market. The rising focus on research and development in biopharmaceuticals and the increasing application of glycobiology in drug discovery and disease diagnosis are major growth drivers. The ongoing advancements in mass spectrometry and chromatography technologies further fuel market expansion by enabling more accurate and efficient glycan analysis. Additionally, the growing prevalence of chronic diseases, such as cancer and diabetes, underscores the importance of glycobiology in developing targeted therapies, thereby boosting market growth. The expanding use of glycan biomarkers in early disease detection and the growing interest in glyco-engineering for therapeutic applications also contribute significantly to the market's growth.
Market Restraints:
Despite the promising growth prospects, the Glycobiology Market faces challenges related to the complexity of glycan analysis and the high costs associated with advanced glycobiology research tools. The market growth may be hindered by the lack of standardized protocols and the need for specialized expertise in glycan analysis, which can limit the adoption of glycobiology technologies in smaller research institutions. Additionally, the integration of glycobiology into clinical practice is still in its nascent stages, posing challenges in translating research findings into therapeutic applications. Addressing these issues requires ongoing investment in training and education, as well as the development of cost-effective tools and techniques to make glycobiology more accessible to a broader range of researchers and clinicians.
Market Opportunities:
The market presents significant opportunities driven by the increasing adoption of glycan-based diagnostics and the rising demand for innovative therapeutic solutions. The development of next-generation glycan analysis tools with higher sensitivity and specificity caters to the growing need for precision medicine. The expansion of research activities in emerging economies and the increasing collaboration between academic institutions and biopharmaceutical companies provide new channels for market growth, allowing for the exploration of novel applications of glycobiology in disease treatment and prevention. Strategic partnerships, investments in cutting-edge technologies, and the introduction of glycan-based personalized medicine are essential for capitalizing on emerging opportunities and maintaining market leadership.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the Glycobiology Market globally?
- Which types and applications of glycobiology are leading the adoption in various sectors?
- How are technological advancements influencing the competitive landscape of the Glycobiology Market?
- Who are the key players in the Glycobiology Market, and what strategies are they employing to stay competitive?
- What are the emerging trends and future prospects in the global Glycobiology Market?
Competitive Intelligence and Business Strategy:
Leading players in the global Glycobiology Market, including Thermo Fisher Scientific, Agilent Technologies, and Merck KGaA, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest heavily in R&D to develop advanced glycobiology tools and explore new applications in drug development and diagnostics. Collaborations with academic institutions, research organizations, and biotechnology firms facilitate market access and promote the adoption of new technologies. Emphasis on customer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Glycobiology Market landscape.
Key Companies Profiled:
- Glycodiag
- Tracxn Technologies Limited
- Agilent Tecnologies, Inc.
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life,Inc.
- Z Biotech,LLC.
- Chemily Glycoscience
- Lectenz Bio
- 2BScientific
Glycobiology Market Industry Segmentation
Product:
- Instruments
- Enzymes
- Consumables
- Kits and Reagents
By Enzyme:
- Galactosidases
- GlcNAc Transferases
- Fucosyltransferases
- GalNAc Transferases
- Galactosyl Transferases
- Glucuronosyltransferases
- Glucosyltransferases
- Pentosyltransferases
- Carbohydrate Kinases
- Neuraminidases
- Sialyltransferases
- Others
Application:
- Drug Discovery and Development
- Diagnostic Applications
- Industrial Applications
- Therapeutic Applications
- Others
End User:
- Biopharmaceutical Companies
- Research Laboratories
- Hospitals
- Diagnostic Centers
- Contract Research Organizations
- Biotechnology Industries
- Academic Institutes
- Others
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation / Development Trends
4. Key Success Factors
- 4.1. Product Adoption / Usage Analysis
- 4.2. Product USPs / Features
- 4.3. Recent Product Approval and Launches
- 4.4. PESTLE Analysis
- 4.5. Porter's Analysis
- 4.6. Regulatory Scenario
- 4.7. Value Chain Analysis
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Enzymes Market Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Rising Geriatric Population
- 5.2.2. Funding Through Government Bodies
- 5.2.3. Technological Advancements
- 5.2.4. Mergers and Acquisitions
- 5.2.5. Cost of Glycobiology Products
- 5.2.6. Increasing Incidence of Congenital Disorders
- 5.2.7. Growing Investments in Precision Medicine Development
- 5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Enzyme
- 6.1.3. By Application
- 6.1.4. By End User
- 6.1.5. By Region
- 6.2. 2024 Market Scenario
7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
- 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
- 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
- 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
- 8.3.1. Instruments
- 8.3.2. Enzymes
- 8.3.3. Consumables
- 8.3.4. Kits and Reagents
- 8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Enzyme
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Bn) Analysis By Enzyme, 2019-2023
- 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Enzyme, 2024-2033
- 9.3.1. Galactosidases
- 9.3.1.1. Fucosidases
- 9.3.1.2. Chitinases
- 9.3.1.3. Acetylgalactosaminidase
- 9.3.1.4. Heparinase
- 9.3.1.5. PNGase F
- 9.3.1.6. Others
- 9.3.2. GlcNAc Transferases
- 9.3.2.1. Acetylglucosaminyltransferase
- 9.3.2.2. Exostosin
- 9.3.2.3. Others
- 9.3.3. Fucosyltransferases
- 9.3.4. GalNAc Transferases
- 9.3.5. Galactosyl Transferases
- 9.3.6. Glucuronosyltransferases
- 9.3.7. Glucosyltransferases
- 9.3.8. Pentosyltransferases
- 9.3.9. Carbohydrate Kinases
- 9.3.10. Neuraminidases
- 9.3.11. Sialyltransferases
- 9.3.12. Others
- 9.3.1. Galactosidases
- 9.4. Market Attractiveness Analysis By Enzyme
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
- 10.3.1. Drug Discovery and Development
- 10.3.2. Diagnostic Applications
- 10.3.2.1. Oncology
- 10.3.2.2. Immunology
- 10.3.2.3. Others
- 10.3.3. Industrial Applications
- 10.3.4. Therapeutic Applications
- 10.3.4.1. Oncology
- 10.3.4.2. Immunology
- 10.3.4.3. Others
- 10.3.5. Others
- 10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
- 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 11.3.1. Biopharmaceutical Companies
- 11.3.2. Research Laboratories
- 11.3.3. Hospitals
- 11.3.4. Diagnostic Centres
- 11.3.5. Contract Research Organizations
- 11.3.6. Biotechnology Industries
- 11.3.7. Academic Institutes
- 11.3.8. Others
- 11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
- 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. South Asia
- 12.3.5. East Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa (MEA)
- 12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2019-2023 and Forecast 2024-2033
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
- 13.3.1.1. U.S.
- 13.3.1.2. Canada
- 13.3.2. By Product
- 13.3.3. By Enzyme
- 13.3.4. By Application
- 13.3.5. By End User
- 13.3.1. By Country
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Enzyme
- 13.4.4. By Application
- 13.4.5. By End User
- 13.5. Country Level Analysis & Forecast
- 13.5.1. U.S. Market Analysis
- 13.5.1.1. Introduction
- 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.5.1.2.1. By Product
- 13.5.1.2.2. By Enzyme
- 13.5.1.2.3. By Application
- 13.5.1.2.4. By End User
- 13.5.2. Canada Market Analysis
- 13.5.2.1. Introduction
- 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.5.2.2.1. By Product
- 13.5.2.2.2. By Enzyme
- 13.5.2.2.3. By Application
- 13.5.2.2.4. By End User
- 13.5.1. U.S. Market Analysis
- 13.6. Market Trends
- 13.7. Key Market Participants - Intensity Mapping
- 13.8. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
- 14.3.1.1. Brazil
- 14.3.1.2. Mexico
- 14.3.1.3. Argentina
- 14.3.1.4. Rest of Latin America
- 14.3.2. By Enzyme
- 14.3.3. By Application
- 14.3.4. By End User
- 14.3.1. By Country
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Enzyme
- 14.4.4. By Application
- 14.4.5. By End User
- 14.5. Country Level Analysis & Forecast
- 14.5.1. Brazil Market Analysis
- 14.5.1.1. Introduction
- 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.1.2.1. By Product
- 14.5.1.2.2. By Enzyme
- 14.5.1.2.3. By Application
- 14.5.1.2.4. By End User
- 14.5.2. Mexico Market Analysis
- 14.5.2.1. Introduction
- 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.2.2.1. By Product
- 14.5.2.2.2. By Enzyme
- 14.5.2.2.3. By Application
- 14.5.2.2.4. By End User
- 14.5.3. Argentina Market Analysis
- 14.5.3.1. Introduction
- 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.3.2.1. By Product
- 14.5.3.2.2. By Enzyme
- 14.5.3.2.3. By Application
- 14.5.3.2.4. By End User
- 14.5.1. Brazil Market Analysis
- 14.6. Market Trends
- 14.7. Key Market Participants - Intensity Mapping
- 14.8. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2019-2023 and Forecast 2024-2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2024-2033
- 15.3.1. By Country
- 15.3.1.1. Germany
- 15.3.1.2. France
- 15.3.1.3. Italy
- 15.3.1.4. U.K.
- 15.3.1.5. Spain
- 15.3.1.6. Russia
- 15.3.1.7. BENELUX
- 15.3.1.8. Nordic Countries
- 15.3.1.9. Rest of Europe
- 15.3.2. By Product
- 15.3.3. By Enzyme
- 15.3.4. By Application
- 15.3.5. By End User
- 15.3.1. By Country
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Enzyme
- 15.4.4. By Application
- 15.4.5. By End User
- 15.5. Country Level Analysis & Forecast
- 15.5.1. Germany Market Analysis
- 15.5.1.1. Introduction
- 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.1.2.1. By Product
- 15.5.1.2.2. By Enzyme
- 15.5.1.2.3. By Application
- 15.5.1.2.4. By End User
- 15.5.2. France Market Analysis
- 15.5.2.1. Introduction
- 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.2.2.1. By Product
- 15.5.2.2.2. By Enzyme
- 15.5.2.2.3. By Application
- 15.5.2.2.4. By End User
- 15.5.3. Italy Market Analysis
- 15.5.3.1. Introduction
- 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.3.2.1. By Product
- 15.5.3.2.2. By Enzyme
- 15.5.3.2.3. By Application
- 15.5.3.2.4. By End User
- 15.5.4. U.K. Market Analysis
- 15.5.4.1. Introduction
- 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.4.2.1. By Product
- 15.5.4.2.2. By Enzyme
- 15.5.4.2.3. By Application
- 15.5.4.2.4. By End User
- 15.5.5. Spain Market Analysis
- 15.5.5.1. Introduction
- 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.5.2.1. By Product
- 15.5.5.2.2. By Enzyme
- 15.5.5.2.3. By Application
- 15.5.5.2.4. By End User
- 15.5.6. Russia Market Analysis
- 15.5.6.1. Introduction
- 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.6.2.1. By Product
- 15.5.6.2.2. By Enzyme
- 15.5.6.2.3. By Application
- 15.5.6.2.4. By End User
- 15.5.7. Nordic Countries Market Analysis
- 15.5.7.1. Introduction
- 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.7.2.1. By Product
- 15.5.7.2.2. By Enzyme
- 15.5.7.2.3. By Application
- 15.5.7.2.4. By End User
- 15.5.8. BENELUX Market Analysis
- 15.5.8.1. Introduction
- 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.8.2.1. By Product
- 15.5.8.2.2. By Enzyme
- 15.5.8.2.3. By Application
- 15.5.8.2.4. By End User
- 15.5.1. Germany Market Analysis
- 15.6. Market Trends
- 15.7. Key Market Participants - Intensity Mapping
- 15.8. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
- 16.3.1.1. India
- 16.3.1.2. Thailand
- 16.3.1.3. Indonesia
- 16.3.1.4. Malaysia
- 16.3.1.5. Rest of South Asia
- 16.3.2. By Product
- 16.3.3. By Enzyme
- 16.3.4. By Application
- 16.3.5. By End User
- 16.3.1. By Country
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Enzyme
- 16.4.4. By Application
- 16.4.5. By End User
- 16.5. Country Level Analysis & Forecast
- 16.5.1. India Market Analysis
- 16.5.1.1. Introduction
- 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.1.2.1. By Product
- 16.5.1.2.2. By Enzyme
- 16.5.1.2.3. By Application
- 16.5.1.2.4. By End User
- 16.5.2. Thailand Market Analysis
- 16.5.2.1. Introduction
- 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.2.2.1. By Product
- 16.5.2.2.2. By Enzyme
- 16.5.2.2.3. By Application
- 16.5.2.2.4. By End User
- 16.5.3. Indonesia Market Analysis
- 16.5.3.1. Introduction
- 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.3.2.1. By Product
- 16.5.3.2.2. By Enzyme
- 16.5.3.2.3. By Application
- 16.5.3.2.4. By End User
- 16.5.4. Malaysia Market Analysis
- 16.5.4.1. Introduction
- 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.4.2.1. By Product
- 16.5.4.2.2. By Enzyme
- 16.5.4.2.3. By Application
- 16.5.4.2.4. By End User
- 16.5.1. India Market Analysis
- 16.6. Market Trends
- 16.7. Key Market Participants - Intensity Mapping
- 16.8. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
- 17.3.1.1. China
- 17.3.1.2. Japan
- 17.3.1.3. South Korea
- 17.3.2. By Product
- 17.3.3. By Enzyme
- 17.3.4. By Application
- 17.3.5. By End User
- 17.3.1. By Country
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Enzyme
- 17.4.4. By Application
- 17.4.5. By End User
- 17.5. Country Level Analysis & Forecast
- 17.5.1. China Market Analysis
- 17.5.1.1. Introduction
- 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.1.2.1. By Product
- 17.5.1.2.2. By Enzyme
- 17.5.1.2.3. By Application
- 17.5.1.2.4. By End User
- 17.5.2. Japan Market Analysis
- 17.5.2.1. Introduction
- 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.2.2.1. By Product
- 17.5.2.2.2. By Enzyme
- 17.5.2.2.3. By Application
- 17.5.2.2.4. By End User
- 17.5.3. South Korea Market Analysis
- 17.5.3.1. Introduction
- 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.3.2.1. By Product
- 17.5.3.2.2. By Enzyme
- 17.5.3.2.3. By Application
- 17.5.3.2.4. By End User
- 17.5.1. China Market Analysis
- 17.6. Market Trends
- 17.7. Key Market Participants - Intensity Mapping
- 17.8. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 18.3.1. By Country
- 18.3.1.1. Australia
- 18.3.1.2. New Zealand
- 18.3.2. By Product
- 18.3.3. By Enzyme
- 18.3.4. By Application
- 18.3.5. By End User
- 18.3.1. By Country
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Enzyme
- 18.4.4. By Application
- 18.4.5. By End User
- 18.5. Country Level Analysis & Forecast
- 18.5.1. Australia Market Analysis
- 18.5.1.1. Introduction
- 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.1.2.1. By Product
- 18.5.1.2.2. By Enzyme
- 18.5.1.2.3. By Application
- 18.5.1.2.4. By End User
- 18.5.2. New Zealand Market Analysis
- 18.5.2.1. Introduction
- 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.2.2.1. By Product
- 18.5.2.2.2. By Enzyme
- 18.5.2.2.3. By Application
- 18.5.2.2.4. By End User
- 18.5.1. Australia Market Analysis
- 18.6. Market Trends
- 18.7. Key Market Participants - Intensity Mapping
- 18.8. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
- 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 19.3.1. By Country
- 19.3.1.1. GCC Countries
- 19.3.1.2. Turkiye
- 19.3.1.3. Northern Africa
- 19.3.1.4. South Africa
- 19.3.1.5. Rest of Middle East and Africa
- 19.3.2. By Product
- 19.3.3. By Enzyme
- 19.3.4. By Application
- 19.3.5. By End User
- 19.3.1. By Country
- 19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Enzyme
- 19.4.4. By Application
- 19.4.5. By End User
- 19.5. Country Level Analysis & Forecast
- 19.5.1. GCC Countries Market Analysis
- 19.5.1.1. Introduction
- 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.1.2.1. By Product
- 19.5.1.2.2. By Enzyme
- 19.5.1.2.3. By Application
- 19.5.1.2.4. By End User
- 19.5.2. Turkiye Market Analysis
- 19.5.2.1. Introduction
- 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.2.2.1. By Product
- 19.5.2.2.2. By Enzyme
- 19.5.2.2.3. By Application
- 19.5.2.2.4. By End User
- 19.5.3. Northern Africa Market Analysis
- 19.5.3.1. Introduction
- 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.3.2.1. By Product
- 19.5.3.2.2. By Enzyme
- 19.5.3.2.3. By Application
- 19.5.3.2.4. By End User
- 19.5.4. South Africa Market Analysis
- 19.5.4.1. Introduction
- 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.4.2.1. By Product
- 19.5.4.2.2. By Enzyme
- 19.5.4.2.3. By Application
- 19.5.4.2.4. By End User
- 19.5.1. GCC Countries Market Analysis
- 19.6. Market Trends
- 19.7. Key Market Participants - Intensity Mapping
- 19.8. Drivers and Restraints - Impact Analysis
20. Market Structure Analysis
- 20.1. Market Analysis by Tier of Companies
- 20.2. Market Share Analysis of Top Players
- 20.3. Market Presence Analysis
21. Competition Analysis
- 21.1. Competition Dashboard
- 21.2. Branding and Promotional Strategies
- 21.3. Key Development Analysis
- 21.4. Competition Deep Dive
- 21.4.1. Glycodiag
- 21.4.1.1. Overview
- 21.4.1.2. Product Portfolio
- 21.4.1.3. Key Financials
- 21.4.1.4. Sales Footprint
- 21.4.1.5. SWOT Analysis
- 21.4.1.6. Strategy Overview
- 21.4.2. Tracxn Technologies Limited
- 21.4.2.1. Overview
- 21.4.2.2. Product Portfolio
- 21.4.2.3. Key Financials
- 21.4.2.4. Sales Footprint
- 21.4.2.5. SWOT Analysis
- 21.4.2.6. Strategy Overview
- 21.4.3. Agilent Tecnologies, Inc.
- 21.4.3.1. Overview
- 21.4.3.2. Product Portfolio
- 21.4.3.3. Key Financials
- 21.4.3.4. Sales Footprint
- 21.4.3.5. SWOT Analysis
- 21.4.3.6. Strategy Overview
- 21.4.4. Takara Bio Inc.
- 21.4.4.1. Overview
- 21.4.4.2. Product Portfolio
- 21.4.4.3. Key Financials
- 21.4.4.4. Sales Footprint
- 21.4.4.5. SWOT Analysis
- 21.4.4.6. Strategy Overview
- 21.4.5. Bio-Techne
- 21.4.5.1. Overview
- 21.4.5.2. Product Portfolio
- 21.4.5.3. Key Financials
- 21.4.5.4. Sales Footprint
- 21.4.5.5. SWOT Analysis
- 21.4.5.6. Strategy Overview
- 21.4.6. Bruker Corporation
- 21.4.6.1. Overview
- 21.4.6.2. Product Portfolio
- 21.4.6.3. Key Financials
- 21.4.6.4. Sales Footprint
- 21.4.6.5. SWOT Analysis
- 21.4.6.6. Strategy Overview
- 21.4.7. Thermo Fisher Scientific Inc.
- 21.4.7.1. Overview
- 21.4.7.2. Product Portfolio
- 21.4.7.3. Key Financials
- 21.4.7.4. Sales Footprint
- 21.4.7.5. SWOT Analysis
- 21.4.7.6. Strategy Overview
- 21.4.8. Shimadzu Corporation
- 21.4.8.1. Overview
- 21.4.8.2. Product Portfolio
- 21.4.8.3. Key Financials
- 21.4.8.4. Sales Footprint
- 21.4.8.5. SWOT Analysis
- 21.4.8.6. Strategy Overview
- 21.4.9. New England Biolabs.
- 21.4.9.1. Overview
- 21.4.9.2. Product Portfolio
- 21.4.9.3. Key Financials
- 21.4.9.4. Sales Footprint
- 21.4.9.5. SWOT Analysis
- 21.4.9.6. Strategy Overview
- 21.4.10. Waters.co.
- 21.4.10.1. Overview
- 21.4.10.2. Product Portfolio
- 21.4.10.3. Key Financials
- 21.4.10.4. Sales Footprint
- 21.4.10.5. SWOT Analysis
- 21.4.10.6. Strategy Overview
- 21.4.11. Merck KGaA
- 21.4.11.1. Overview
- 21.4.11.2. Product Portfolio
- 21.4.11.3. Key Financials
- 21.4.11.4. Sales Footprint
- 21.4.11.5. SWOT Analysis
- 21.4.11.6. Strategy Overview
- 21.4.12. Palleon Pharmaceuticals
- 21.4.12.1. Overview
- 21.4.12.2. Product Portfolio
- 21.4.12.3. Key Financials
- 21.4.12.4. Sales Footprint
- 21.4.12.5. SWOT Analysis
- 21.4.12.6. Strategy Overview
- 21.4.13. Asparia Glycomics
- 21.4.13.1. Overview
- 21.4.13.2. Product Portfolio
- 21.4.13.3. Key Financials
- 21.4.13.4. Sales Footprint
- 21.4.13.5. SWOT Analysis
- 21.4.13.6. Strategy Overview
- 21.4.14. RayBiotech Life,Inc.
- 21.4.14.1. Overview
- 21.4.14.2. Product Portfolio
- 21.4.14.3. Key Financials
- 21.4.14.4. Sales Footprint
- 21.4.14.5. SWOT Analysis
- 21.4.14.6. Strategy Overview
- 21.4.15. Z Biotech,LLC.
- 21.4.15.1. Overview
- 21.4.15.2. Product Portfolio
- 21.4.15.3. Key Financials
- 21.4.15.4. Sales Footprint
- 21.4.15.5. SWOT Analysis
- 21.4.15.6. Strategy Overview
- 21.4.16. Chemily Glycoscience
- 21.4.16.1. Overview
- 21.4.16.2. Product Portfolio
- 21.4.16.3. Key Financials
- 21.4.16.4. Sales Footprint
- 21.4.16.5. SWOT Analysis
- 21.4.16.6. Strategy Overview
- 21.4.17. Lectenz Bio
- 21.4.17.1. Overview
- 21.4.17.2. Product Portfolio
- 21.4.17.3. Key Financials
- 21.4.17.4. Sales Footprint
- 21.4.17.5. SWOT Analysis
- 21.4.17.6. Strategy Overview
- 21.4.18. 2BScientific
- 21.4.18.1. Overview
- 21.4.18.2. Product Portfolio
- 21.4.18.3. Key Financials
- 21.4.18.4. Sales Footprint
- 21.4.18.5. SWOT Analysis
- 21.4.18.6. Strategy Overview
- 21.4.1. Glycodiag
